21.10.2020 • News

AkzoNobel Buys Spain’s Titan

Dutch paints and coatings group AkzoNobel has agreed to buy the decorative paints business of Spain’s Industrias Titan for an undisclosed sum.

The deal is expected to close by the end of quarter one 2021, subject to receiving regulatory clearance.

“The Spanish market has strong growth potential and this is an excellent opportunity for us to reinforce our position in the region,” says AkzoNobel CEO Thierry Vanlancker. “The acquisition will enable us to better serve our customers and provides added momentum, while also offering further proof of us being the reference in paints and coatings in Europe.

Headquartered in Barcelona, Titan has manufacturing plants in El Prat de Llobregat (Barcelona), Seville, Gran Canaria (Canary Islands), Porto in Portugal and Tangier in Morocco. The company, which had sales of about €80 million last year, is regarded as one of Spain’s best-known brands – it sells paints under the name Titanlux.

AkzoNobel said Titan shares its commitment to sustainable innovation with much of its portfolio having been recognized for environmental performance.

Author: Elaine Burridge, Freelance Journalist

AkzoNobel is to buy the decorative paints business of Spain’s Industrias...
AkzoNobel is to buy the decorative paints business of Spain’s Industrias Titan for an undisclosed sum. The deal is expected to close by end-Q1 2021. Titan has manufacturing plants in Barcelona, Seville, Gran Canaria (Canary Islands), Porto in Portugal and Tangier in Morocco. (c) AkzoNobel

Company

Logo:

AkzoNobel

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.